西尼罗河病毒特异性抗体在病毒血症献血者中的持续存在情况。
Persistence of West Nile virus-specific antibodies in viremic blood donors.
作者信息
Prince Harry E, Tobler Leslie H, Yeh Cindy, Gefter Nelly, Custer Brian, Busch Michael P
机构信息
Focus Diagnostics, Cypress, California, USA.
出版信息
Clin Vaccine Immunol. 2007 Sep;14(9):1228-30. doi: 10.1128/CVI.00233-07. Epub 2007 Jul 25.
Abstract
We evaluated West Nile virus (WNV) antibody persistence by using follow-up plasma samples from 35 blood donors who made viremic donations in 2005. At 26 to 34 days of follow-up, all of the donors (n = 33) were positive for WNV immunoglobulin M (IgM), IgA, and IgG. At 1-year of follow-up, 17% of the donors (n = 23) were positive for WNV IgM, 57% were positive for WNV IgA, and 100% were positive for WNV IgG.
摘要
我们通过使用2005年出现病毒血症的35名献血者的随访血浆样本，评估了西尼罗河病毒（WNV）抗体的持久性。在随访的26至34天，所有献血者（n = 33）的WNV免疫球蛋白M（IgM）、IgA和IgG均呈阳性。在随访1年时，17%的献血者（n = 23）WNV IgM呈阳性，57%的献血者WNV IgA呈阳性，100%的献血者WNV IgG呈阳性。
相似文献
1
Persistence of West Nile virus-specific antibodies in viremic blood donors.
Clin Vaccine Immunol. 2007 Sep;14(9):1228-30. doi: 10.1128/CVI.00233-07. Epub 2007 Jul 25.
2
Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.
J Clin Microbiol. 2005 Sep;43(9):4316-20. doi: 10.1128/JCM.43.9.4316-4320.2005.
3
West Nile virus in Canadian blood donors.
Transfusion. 2005 Apr;45(4):487-91. doi: 10.1111/j.0041-1132.2005.04384.x.
4
Persistence of antibodies to West Nile virus nonstructural protein 5.
J Clin Virol. 2008 Sep;43(1):102-6. doi: 10.1016/j.jcv.2008.03.025. Epub 2008 May 8.
5
Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus.
Clin Vaccine Immunol. 2006 Jan;13(1):33-6. doi: 10.1128/CVI.13.1.33-36.2006.
6
Virus and antibody dynamics in acute west nile virus infection.
J Infect Dis. 2008 Oct 1;198(7):984-93. doi: 10.1086/591467.
7
Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay.
Clin Diagn Lab Immunol. 2005 Jan;12(1):231-3. doi: 10.1128/CDLI.12.1.231-233.2005.
8
West Nile virus immunoglobulin A (WNV IgA) detection in cerebrospinal fluid in relation to WNV IgG and IgM reactivity.
J Clin Virol. 2006 Nov;37(3):174-8. doi: 10.1016/j.jcv.2006.07.005. Epub 2006 Aug 30.
9
Persistence of West Nile virus immunoglobulin M antibodies, Greece.
J Med Virol. 2011 Oct;83(10):1857-60. doi: 10.1002/jmv.22190.
引用本文的文献
1
Powassan and Eastern Equine Encephalitis Virus Seroprevalence in Endemic Areas, United States, 2019-2020.
Emerg Infect Dis. 2025 May;31(5):929-936. doi: 10.3201/eid3105.240893.
2
Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels.
Viruses. 2024 Jul 3;16(7):1075. doi: 10.3390/v16071075.
3
Comparison of West Nile Virus Disease in Humans and Horses: Exploiting Similarities for Enhancing Syndromic Surveillance.
Viruses. 2023 May 24;15(6):1230. doi: 10.3390/v15061230.
4
Assessing West Nile virus (WNV) and Usutu virus (USUV) exposure in bird ringers in the Netherlands: a high-risk group for WNV and USUV infection?
One Health. 2023 Apr 7;16:100533. doi: 10.1016/j.onehlt.2023.100533. eCollection 2023 Jun.
5
Modelling Japanese encephalitis virus transmission dynamics and human exposure in a Cambodian rural multi-host system.
PLoS Negl Trop Dis. 2022 Jul 11;16(7):e0010572. doi: 10.1371/journal.pntd.0010572. eCollection 2022 Jul.
6
Duration of West Nile Virus Immunoglobulin M Antibodies up to 81 Months Following West Nile Virus Disease Onset.
Am J Trop Med Hyg. 2022 Apr 11;106(6):1721-4. doi: 10.4269/ajtmh.21-1234.
7
Zika Virus IgM 25 Months after Symptom Onset, Miami-Dade County, Florida, USA.
Emerg Infect Dis. 2019 Dec;25(12):2264-2265. doi: 10.3201/eid2512.191022.
8
Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses.
MMWR Recomm Rep. 2019 Jun 14;68(1):1-10. doi: 10.15585/mmwr.rr6801a1.
9
Zika Virus IgM Detection and Neutralizing Antibody Profiles 12-19 Months after Illness Onset.
Emerg Infect Dis. 2019 Feb;25(2):299-303. doi: 10.3201/eid2502.181286.
10
Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity.
Clin Vaccine Immunol. 2017 Apr 5;24(4). doi: 10.1128/CVI.00036-17. Print 2017 Apr.
本文引用的文献
1
Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.
J Clin Microbiol. 2005 Sep;43(9):4316-20. doi: 10.1128/JCM.43.9.4316-4320.2005.
2
Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
N Engl J Med. 2005 Aug 4;353(5):460-7. doi: 10.1056/NEJMoa044029.
3
West Nile virus among blood donors in the United States, 2003 and 2004.
N Engl J Med. 2005 Aug 4;353(5):451-9. doi: 10.1056/NEJMoa044333.
4
Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay.
Clin Diagn Lab Immunol. 2005 Jan;12(1):231-3. doi: 10.1128/CDLI.12.1.231-233.2005.
5
Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies.
J Clin Microbiol. 2004 Oct;42(10):4641-8. doi: 10.1128/JCM.42.10.4641-4648.2004.
6
Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases.
Emerg Infect Dis. 2003 Mar;9(3):376-9. doi: 10.3201/eid0903.020531.
7
West Nile virus: a primer for the clinician.
Ann Intern Med. 2002 Aug 6;137(3):173-9. doi: 10.7326/0003-4819-137-3-200208060-00009.
Zotero 插件